• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Molecular pathobiological Study on Endothelial Function Ocurring during Vascular Remodeling

Research Project

Project/Area Number 10307003
Research Category

Grant-in-Aid for Scientific Research (A).

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

SUEISHI Katsuo  Faculty of Medicine, KYUSHU UNIVERSITY, Prof., 大学院・医学研究院, 教授 (70108710)

Co-Investigator(Kenkyū-buntansha) YONEMITSU Yoshikazu  Faculty of Medicine, KYUSHU UNIVERSITY, Assistant, 医学部・附属病院, 助手 (40315065)
NAKAGAWA Kazunori  Faculty of Medicine, KYUSHU UNIVERSITY, Lecturer, 大学院・医学研究院, 講師 (50217668)
NAKASHIMA Yutaka  Faculty of Medicine, KYUSHU UNIVERSITY, Ass.Prof., 大学院・医学研究院, 助教授 (50135349)
Project Period (FY) 1998 – 2000
Keywordsgene transfer vector / Sev / VEGF / FGF-2 / MCP-1 / angiogenesis / atherosclerosis / vascular remodeling
Research Abstract

The major results obtained in the last year (from Apr., 2000 to Mar., 2001) were as follows :
1. Investigation on biological properties of Sendai virus vector (SeV) : 1) the in vitro and in vivo efficiencies of transduction and expression of beta-gal., luciferase, ecNOS, VEGF, FGF-2 and other genes using SeV were almost the same as those by Adeno virus vector, and SeV-mediated gene transfer was characterized by the fact that its brief exposure to cells in vitro and in vivo, less than 10 min., was enough for the peak gene expression. 2) Intaluminal injection of reporter gene-SeV could label not only ECs but also medial SMCs, but the neointima ocurred in human varicose veins hampered the transfection of medial SMCs.
2. Molecular mechanism of angiogenesis in ischemic tissues : 1) Effect of intramuscular injection of VEGF and FGF-2 genes-SeV on development of collateral vessels in ischemic limb mouse model : injection of FGF-2 gene could induce endogeneous VEGF overexpression, and markedly i … More mprove blood perfusion in the ischemic limb by enhanced angiogenesis. However, VEGF gene injection worsened blood perfusion in ischemic limb. 2) the final and target angiogenic molecule for accelerating the development of collateral vessels in ischemic tissues was VEGF, but the harmonized collaboration of other angiogenic factors including FGF-2 was necessary for developing effective collateral circulation.
3. In rat pulmonary hypertension induced by monocrotaline, interstitial remodeling by function of infiltrating macrophages through MCP-1 was revealed to be most important in development of pulmonary hypertension, and intramuscular infection of 7ND MCP-1 gene was effective for its prevention.
4. Pigmentary retinopathy was revealed to be an angiogenic disease by the development of animal models of retroretinal angiogenesis by overexpression of VEGF using SeV.
5. Diffuse intimal thickening was revealed to be an atherosclerosis-prone lesion by systematically and morphometrically examining human arteries including aorta, coronary artery, basilar artery of brain and others. Less

  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Masaki I, et al: "Recombinant Sendai virus-mediated gene transfer to vasculature : a new class of efficient gene transfer vector to the vascular system."FASEB J. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishibashi H, et al: "Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor β 1, and tissue factor and also cell growth and invasion activities."Cancer Res. 60. 6531-6536 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Egashira K, et al: "Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats : blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis "FASEB J. 14. 1974-197* (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitamoto S, et al: "Increased activity of nuclear factor-κ B participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats."Circulation. 102. 806-812 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yonemitsu Y, et al.: "Efficient gene transfer to airway epithelium using recombinant Sendai virus."Nat Biotechnol. 18. 970-973 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sakamoto T, et al: "Target gene transfer of tissue plasminogen activator to cornea by electric pulse inhibits intracameral fibrin formation and corneal cloudiness."Hum Gene Ther. 10. 2551-2557 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 居石克夫: "血管新生研究の新展開"医薬ジャーナル社. 9 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 畑快右: "血管研究の最前線に迫る"羊土社. 9 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masaki I, Yonemitsu Y, Komori K, Ueno H, Nakashima Y, Nakagawa K, Fukumura M, Kato A, Hasan M, Nagai Y, Sugimachi K, Alton EWFW, Hasegawa M, Sueishi K.: "Recombinant Sendai virus-mediated gene transfer to vasculature : a new class of efficient gene transfer vector to the vascular system."FASEB J. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishibashi H, Nakagwa K, Onimaru M, Castellanous EJ, Kaneda Y, Nakashima Y, Shirasuna K, Sueishi K.: "Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor β1, and tissue factor and also cell growth and invasion activities."Cancer Res. 60. 6531-6536 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Egashira K, Koyanagi M, Kitamoto S, Ni Weihua, Kataoka C, Morishita R, Kaneda Y, Akiyama C, Nishida K, Sueishi K, Takeshita A.: "Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats : blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis."FASEB J. 14. 1974-1978 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshikawa H, Ishibashi T, Hata Y, Inomata H, Sueishi K.: "The suppressive effect of tecogalan sodium on in vitro angiogenesis via the periendothelial proteolytic activities."Ophthalmic Res. 32. 261-269 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitamoto S, Egashira K, Kataoka C, Koyanagi M, Katoh M, Shimokawa H, Morishita R, Kaneda Y, Sueishi K, Takeshita A.: "Increased activity of nuclear factor-κB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats."Circulation. 102. 806-812 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakagawa K, Chen Y-X, Ishibashi H, Yonemitsu Y, Murata T, Hata Y, Nakashima Y, Sueishi K.: "Angiogenesis and its regulation : roles of vascular endothelial cell growth factor."Semin Thromb Hemost. 26. 61-66 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yonemitsu Y, Kitson C, Ferrari S, Farley R, Griesenbach U, Judd D, Steel R, Scheid P, Zhu J, Jeffery PK, Kato A, Hasan MK, Nagai Y, Masaki I, Fukumura M, Hasegawa M, Geddes DM, Alton EWFW.: "Efficient gene transfer to airway epithelium using recombinant Sendai virus."Nat Biotechnol. 18. 970-973 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sakamoto T, Oshima Y, Nakagawa K, Ishibashi T, Inomata H, Sueishi K.: "Target gene transfer of tissue plasminogen activator to cornea by electric pulse inhibits intracameral fibrin formation and corneal cloudiness."Hum Gene Ther. 10. 2551-2557 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi